Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis [PDF]
Turk J HaematolAtaş Ü +44 more
europepmc +1 more source
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. [PDF]
LancetGBD 2023 Cancer Collaborators.
europepmc +1 more source
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. [PDF]
LancetGBD 2023 Demographics Collaborators.
europepmc +1 more source
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. [PDF]
Pediatr Infect Dis J, 2013 Siberry GK +13 more
europepmc +1 more source
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. [PDF]
LancetGBD 2023 Disease and Injury and Risk Factor Collaborators.
europepmc +1 more source
21st Turkish Thoracic Society Annual Congress Abstract Supplement. [PDF]
Turk Thorac J, 2018 europepmc +1 more source